International law firm McDermott Will & Schulte represented Solventum, a global healthcare company, in its acquisition of Acera Surgical (Acera), a privately held bioscience company developing engineered materials for regenerative wound care.

The transaction includes an upfront cash payment of $725 million, subject to customary purchase price adjustments, along with up to $125 million in contingent cash payments tied to future milestone achievements. The acquisition enhances Solventum’s advanced wound care offerings with Acera’s synthetic tissue matrix technology.

The McDermott team was led by Andrew Warmus, Ann Marie Brodarick, Ari Banks, and Jake Schindler, with assistance from Micheal Bruno, Alex Cheng-Yi Lee, Kwabena Yeboah, Greg Heltzer, Noah Feldman Greene, Ty Carson, Payton Thorton, Chuck Larsen, Ellie Atkins, Ashley Brzezinski, Taylor MacDonald, David Saunders, Jeff Holdvogt, Jennifer Hill, Brian Mead, Melis Solaksubasi, Jamie Ravitz, Paul Gadiock, Jiayan Chen, Marissa Hill Daley, Jae Hyun Lee, Nicholas Alarif, Dexter Golinghorst, Mark Bilut, Justin Bender, Kristi Mankowske, Betty Brito, and Ash Sivakumar.

Read Solventum’s press release here.

Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.